122 related articles for article (PubMed ID: 12190326)
1. Conformationally constrained nicotines: polycyclic, bridged, and spiro-annulated analogues as novel ligands for the nicotinic acetylcholine receptor.
Ullrich T; Krich S; Binder D; Mereiter K; Anderson DJ; Meyer MD; Pyerin M
J Med Chem; 2002 Aug; 45(18):4047-54. PubMed ID: 12190326
[TBL] [Abstract][Full Text] [Related]
2. (-)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidin-2'-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptor.
Mullen G; Napier J; Balestra M; DeCory T; Hale G; Macor J; Mack R; Loch J; Wu E; Kover A; Verhoest P; Sampognaro A; Phillips E; Zhu Y; Murray R; Griffith R; Blosser J; Gurley D; Machulskis A; Zongrone J; Rosen A; Gordon J
J Med Chem; 2000 Nov; 43(22):4045-50. PubMed ID: 11063601
[TBL] [Abstract][Full Text] [Related]
3. A chiral synthesis of (-)-spiro[1-azabicyclo[2.2.2]octane-3,5'- oxazolidin-2'-one]: a conformationally restricted analogue of acetylcholine that is a potent and selective alpha7 nicotinic receptor agonist.
Macor JE; Mullen G; Verhoest P; Sampognaro A; Shepardson B; Mack RA
J Org Chem; 2004 Sep; 69(19):6493-5. PubMed ID: 15357617
[TBL] [Abstract][Full Text] [Related]
4. In vitro binding characteristics of [3H]AZ11637326, a novel alpha7-selective neuronal nicotinic receptor agonist radioligand.
Gordon JC; Phillips E; Gurley DA; Heys JR; Lazor LA; Barthlow HG; Mallamaci MA; Keith RA
Eur J Pharmacol; 2010 Oct; 645(1-3):63-9. PubMed ID: 20674564
[TBL] [Abstract][Full Text] [Related]
5. A facile synthesis of cis-1-methyl-1,2,3,3a,4,8b- hexahydropyrrolo[3,2-f]pyrindine, an annulated nicotine analog.
Zhai H; Liu P; Luo S; Fang F; Zhao M
Org Lett; 2002 Dec; 4(25):4385-6. PubMed ID: 12465893
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of two fluoro analogues of the nicotinic acetylcholine receptor agonist UB-165.
Sutherland A; Gallagher T; Sharples CG; Wonnacott S
J Org Chem; 2003 Mar; 68(6):2475-8. PubMed ID: 12636420
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (+/-)-UB-165.
Sharples CG; Karig G; Simpson GL; Spencer JA; Wright E; Millar NS; Wonnacott S; Gallagher T
J Med Chem; 2002 Jul; 45(15):3235-45. PubMed ID: 12109907
[TBL] [Abstract][Full Text] [Related]
8. Coaxing a pyridine nucleus to give up its aromaticity: synthesis and pharmacological characterization of novel conformationally restricted analogues of nicotine and anabasine.
Sarkar TK; Basak S; Wainer I; Moaddel R; Yamaguchi R; Jozwiak K; Chen HT; Lin CC
J Med Chem; 2004 Dec; 47(27):6691-701. PubMed ID: 15615518
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and nicotinic binding studies on enantiopure diazine analogues of the novel (2-chloro-5-pyridyl)-9-azabicyclo[4.2.1]non-2-ene UB-165.
Gohlke H; Gündisch D; Schwarz S; Seitz G; Tilotta MC; Wegge T
J Med Chem; 2002 Feb; 45(5):1064-72. PubMed ID: 11855986
[TBL] [Abstract][Full Text] [Related]
10. Homoazanicotine: a structure-affinity study for nicotinic acetylcholine (nACh) receptor binding.
Ferretti G; Dukat M; Giannella M; Piergentili A; Pigini M; Quaglia W; Damaj MI; Martin BR; Glennon RA
J Med Chem; 2002 Oct; 45(21):4724-31. PubMed ID: 12361399
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of diazine containing bioisosteres of (-)-ferruginine as ligands for nicotinic acetylcholine receptors.
Gündisch D; Harms K; Schwarz S; Seitz G; Stubbs MT; Wegge T
Bioorg Med Chem; 2001 Oct; 9(10):2683-91. PubMed ID: 11557356
[TBL] [Abstract][Full Text] [Related]
12. Total synthesis of (±)-parvineostemonine.
Chen ZH; Tian JM; Chen ZM; Tu YQ
Chem Asian J; 2012 Oct; 7(10):2199-202. PubMed ID: 22778054
[No Abstract] [Full Text] [Related]
13. Highly stereoselective [4 + 3] cycloadditions of nitrogen-stabilized oxyallyl cations with pyrroles: an approach to parvineostemonine.
Antoline JE; Hsung RP; Huang J; Song Z; Li G
Org Lett; 2007 Mar; 9(7):1275-8. PubMed ID: 17335226
[TBL] [Abstract][Full Text] [Related]
14. Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine.
Grottick AJ; Trube G; Corrigall WA; Huwyler J; Malherbe P; Wyler R; Higgins GA
J Pharmacol Exp Ther; 2000 Sep; 294(3):1112-9. PubMed ID: 10945867
[TBL] [Abstract][Full Text] [Related]
15. [3H]A-585539 [(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity alpha7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain.
Anderson DJ; Bunnelle W; Surber B; Du J; Surowy C; Tribollet E; Marguerat A; Bertrand D; Gopalakrishnan M
J Pharmacol Exp Ther; 2008 Jan; 324(1):179-87. PubMed ID: 17959745
[TBL] [Abstract][Full Text] [Related]
16. Sugar-based enantiomeric and conformationally constrained pyrrolo[2,1-c][1,4]-benzodiazepines as potential GABAA ligands.
Araújo AC; Rauter AP; Nicotra F; Airoldi C; Costa B; Cipolla L
J Med Chem; 2011 Mar; 54(5):1266-75. PubMed ID: 21314193
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and receptor affinity of novel conformationally restricted σ ligands based on the [4.3.3]propellane scaffold.
Torres-Gómez H; Lehmkuhl K; Schepmann D; Wünsch B
Eur J Med Chem; 2013; 70():78-87. PubMed ID: 24140950
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, optical resolution, absolute configuration, and preliminary pharmacology of (+)- and (-)-cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H- pyrrolo-[3,2-h]isoquinoline, a structural analog of nicotine.
Glassco W; Suchocki J; George C; Martin BR; May EL
J Med Chem; 1993 Oct; 36(22):3381-5. PubMed ID: 8230128
[TBL] [Abstract][Full Text] [Related]
19. Synthetic Methods for the Preparation of Conformationally Restricted Analogues of Nicotine.
Panda B; Albano G
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946630
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, nicotinic acetylcholine receptor binding affinities, and molecular modeling of constrained epibatidine analogues.
Wei ZL; Petukhov PA; Xiao Y; Tückmantel W; George C; Kellar KJ; Kozikowski AP
J Med Chem; 2003 Mar; 46(6):921-4. PubMed ID: 12620069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
